FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

27 letters match. Newest first.

  1. Trinity HealthCare Supply, LLC dba altRx

    FDA warns altRx over misleading website claims for compounded semaglutide and tirzepatide, including 'clinically proven' and wrong compounder label.

    Low
  2. Glow Medispa, LLC dba Mint Med

    FDA warns telehealth seller Mint Med that its website labels falsely suggest it compounds the semaglutide and tirzepatide drugs it sells.

    Low
  3. Roen Health, Inc. dba RoenRx

    FDA warned RoenRx that its website misbrands compounded semaglutide with misleading approval claims and a company label implying it makes the drug.

    Medium
  4. Clover Meds LLC dba Clover Meds

    Clover Meds, a telehealth seller, misbranded compounded semaglutide and tirzepatide with false website claims that it makes the drugs and uses 'FDA-licensed' facilities.

    Medium
  5. Refills Health, LLC dba Refills Health

    FDA told telehealth seller Refills Health its website misbrands compounded semaglutide by implying FDA approval and naming itself as maker.

    Medium
  6. Join Josie

    FDA says Join Josie's website misbranded compounded semaglutide and tirzepatide by falsely implying FDA approval and naming Join Josie as compounder.

    Low
  7. Levity Inc. dba Levity

    FDA warned Levity over misleading website claims for compounded semaglutide and liraglutide, including implying Levity made the drugs and that they were FDA-approved.

    Low
  8. Dripgym Mobile Parent, LLC dba Amp Health

    FDA warned Amp Health that its website misbranded compounded semaglutide and tirzepatide with false maker and approval-implying claims.

    Low
  9. Aspen Aesthetics dba Fifty 410

    FDA warns Fifty 410 over misleading website claims for compounded semaglutide and tirzepatide, including implied compounding and 'clinically proven' claims.

    Low
  10. Get.Fit.Medical, LLC dba Get.Fit.Medical

    FDA warned Get.Fit.Medical that its website sold compounded sildenafil, tadalafil, semaglutide and tirzepatide with false 'generic' claims.

    High risk
  11. Dermacare LLC dba BlueChew

    FDA warned BlueChew over website claims that its compounded sildenafil and tadalafil are the same as Viagra and Cialis.

    High risk
  12. FitRX, LLC dba Zealthy

    FDA warns Zealthy over website claims that compounded semaglutide is the same as Wegovy and Ozempic.

    Medium
  13. Try Nova

    FDA warned Try Nova that its website’s compounded semaglutide claim "Same active ingredient as Wegovy & Ozempic" is false or misleading.

    Low
  14. Lovely Meds, Inc. dba Lovely Meds

    FDA cited Lovely Meds for misleading website claims that compounded semaglutide and tirzepatide are the same as FDA-approved drugs.

    Low
  15. Lyfe Rx

    Lyfe Rx offered compounded semaglutide and tirzepatide online with false 'clinically proven weight loss' claims, FDA says.

    Low
  16. Sprout Health Partners LLC dba Sprout Health

    FDA warned telehealth seller Sprout Health that its website's claim compounded semaglutide and tirzepatide are FDA-approved makes the drugs misbranded.

    Low
  17. Elevate Your Wellness LLC, dba Elevated

    FDA warned Elevated that its website offered compounded semaglutide and tirzepatide with misleading claims they match FDA-approved drugs.

    Low
  18. Healthy Male

    FDA warns Healthy Male that its website sells compounded tirzepatide with false or misleading 'clinically proven' weight-loss claims.

    Low
  19. Invigorate Med Spa

    Invigorate Med Spa's website claimed compounded semaglutide and tirzepatide were Wegovy and Mounjaro, making them misbranded.

    Low
  20. Matthew Stern, CEO MyStart Health LLC.

    FDA warns MyStart Health over 'Generic Ozempic' claims for compounded semaglutide.

    Low
  21. Live Good Inc.

    Live Good Inc. sold Berry Gen Sugar Control supplements as a diabetes treatment without FDA approval, making it an unapproved, misbranded drug.

    High risk
  22. NS Products, Inc.

    FDA and FTC warned NS Products that website claims make NaturaCure an unapproved infertility drug.

    High risk
  23. Fertility Nutraceuticals LLC

    FDA and FTC told Fertility Nutraceuticals its three fertility supplements are unapproved drugs because of disease-treatment claims online and in shipping inserts.

    High risk
  24. LeRoche Benicoeur dba ConceiveEasy

    FDA and FTC warned LeRoche Benicoeur dba ConceiveEasy that its ConceiveEasy fertility product was sold as an unapproved new drug with unsupported disease claims.

    Medium
  25. Sal Nature LLC/FertilHerb

    FDA and FTC warn Sal Nature/FertilHerb that fertility supplement website claims make it an unapproved drug and misbranded.

    Low
  26. EU Natural Inc.

    EU Natural's fertility supplements are unapproved new drugs because website claims treat infertility, PCOS, cancer and other diseases.

    High risk
  27. Coco's Holistic Specialties & Apothecary

    FDA warned Coco's Holistic Specialties & Apothecary that its 4-Thieves teas are unapproved, misbranded drugs sold with COVID-19 treatment claims.

    High risk